PCSK9 and cardiovascular disorder: Lastly, the cardiovascular disease prevention guidelines over the past 2 decades have evolved.2,16,17 These guideline updates span various facets of cardiovascular care, with a notable shift toward personalized risk assessments and the introduction of new medications, such as PCSK9 inhibitors and novel anticoagulants.